Theriva Biologics Files 8-K with Financials

Ticker: TOVX · Form: 8-K · Filed: Jun 2, 2025 · CIK: 894158

Theriva Biologics, Inc. 8-K Filing Summary
FieldDetail
CompanyTheriva Biologics, Inc. (TOVX)
Form Type8-K
Filed DateJun 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-statements, regulation-fd, other-events

TL;DR

Theriva Biologics dropped an 8-K on 5/27, mostly financials and other events. Check it for the latest.

AI Summary

On May 27, 2025, Theriva Biologics, Inc. (formerly Synthetic Biologics, Inc.) filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. Theriva Biologics, Inc. is incorporated in Nevada and its fiscal year ends on December 31.

Why It Matters

This filing provides an update on Theriva Biologics' financial status and other material events, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting routine financial and event information, not indicating any immediate operational or financial distress.

Key Numbers

  • 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

  • Theriva Biologics, Inc. (company) — Registrant
  • Synthetic Biologics, Inc. (company) — Former company name
  • May 27, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of incorporation
  • 13-3808303 (identifier) — IRS Employer Identification No.

FAQ

What specific 'Other Events' are disclosed in this 8-K filing?

The provided text does not detail the specific 'Other Events' beyond listing it as an item information category.

What is the primary purpose of this 8-K filing for Theriva Biologics, Inc.?

The primary purpose is to report on financial statements and exhibits, along with other events and a Regulation FD disclosure, as of May 27, 2025.

When was Theriva Biologics, Inc. previously known as Synthetic Biologics, Inc.?

The filing indicates Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc., with a date of name change not specified in this excerpt.

What is Theriva Biologics, Inc.'s state of incorporation and IRS Employer Identification Number?

Theriva Biologics, Inc. is incorporated in Nevada and its IRS Employer Identification Number is 13-3808303.

What is the SEC file number for Theriva Biologics, Inc.?

The SEC file number for Theriva Biologics, Inc. is 001-12584.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Theriva Biologics, Inc. (TOVX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.